|
MechanismEnvelope glycoprotein gp160 agonists [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Ocean University of China Lantai Pharmaceutical Co. Ltd.
0 Patents (Medical) associated with Ocean University of China Lantai Pharmaceutical Co. Ltd.
100 Deals associated with Ocean University of China Lantai Pharmaceutical Co. Ltd.
100 Translational Medicine associated with Ocean University of China Lantai Pharmaceutical Co. Ltd.